M.S. in Translational Medicine Program

The Master of Science in Translational Medicine is a two-year KGI-Irell and Manella Graduate School of Biological Sciences at City of Hope (IMGS) joint program. Graduates will be uniquely positioned to begin research laboratory careers in the biotechnology/pharmaceutical industry, clinical or academic laboratories, or pursue further education at the doctoral level, medical education or both. This program is aimed at providing students with an applied research experience and an in-depth understanding of how to translate basic research into medical products from the perspectives of both academic research (discovery) and downstream commercial development.
 
MS in Translational Medicine Program Learning Outcomes:
 
  • Generate hypothesis and perform hypothesis-driven research
  • Design research and methodology, and analyze and report data results
  • Assess the literature, identify knowledge gaps, and convey findings to the scientific community
  • Plan the translation of basic science and engineering discoveries into products and processes that benefit society
  • Communicate effectively in an industry environment composed of scientists, engineers and business professionals
  • Adhere to ethical principles in research, development, and business issues inherent in the bioscience industries
  • Tackle complex problems and contribute productively on an interdisciplinary team
     

KGI-IMGS Program Directors

Anastasia Levitin, Ph.D.
Research Assistant Professor, Program Director, M.S.
KGI School of Applied LIfe Sciences
 
Yilun Liu, Ph.D.
Associate Professor, Associate Chair, Department of Cancer Genetics and Epigenetics
Beckman Research Institute, City of Hope
 
 
The Master of Science in Translational Medicine is accredited by the accrediting agency WASC Senior College and University Commission (WSCUC).